Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
April 2016 onwards
Submit An Event
Events - October 2012
Indian Lab Automation 2012
30 Oct 2012 - 31 Oct 2012 - Mumbai, India
This conference will amalgamate the cutting-edge techniques used by leading research institutes. With access to all three tracks, Drug Discovery & Development, Advances in Genomics & Informatics and Advances in Bioanalysis, this conference aims to provide delegates with a comprehensive overview of the essential techniques required to investigate current scientific advancements.
The Flow Chemistry workshop will be taking place prior to this conference.
Drug Discovery & Development
In the ever-expanding field of drug development it is vital for scientists to remain at the forefront of drug discovery and refinement in order to keep up with consumerist demand. With a need for improved specificity and fewer side-effects in patients, our speakers will be discussing the sophisticated details of the fundamental techniques required to develop the most successful drugs.
This branch of analytical chemistry is essential in obtaining accurate quantitative measurements of drug metabolites and macromolecules. Keynote presentations will talk about innovative analytical methods, explain their movement towards a more reliable, rational approach of analysis, and describe the considerable impact these techniques can have on the overall success of pharmaceutical research.
Advances in Genomics and Informatics
Despite the remarkable feat of sequencing the human genome nearly ten years ago, the sheer volume of information that DNA provides us with requires continual advancements in the way we unravel and analyse the data. Our speakers will address numerous methods of analysis, particularly focusing on the exciting areas of epigenetics, miRNA and Next-Gen Sequencing.
For more information on the stimulating research involved in epigenetics, miRNA and Next-Gen Sequencing, please view the information on the Genomics Research Asia conference being held later this year.
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Advertise On This Site
Terms & Conditions
©2015 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,800+ scientific and medical posters
4,000+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FREE!